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A B S T R A C T
A 47-year-old male who previously underwent coronary bypass graft surgery was transferred to our
hospital for treatment of bare metal in-stent restenosis (ISR) of severely calciﬁed left main (LM) coronary
lesion. During a repeat coronary intervention, LM coronary perforation occurred after rotational
atherectomy followed by balloon dilatation. Hemostasis was successfully achieved by implantation of a
single polytetraﬂuoroethylene (PTFE)-covered stent. Although intravascular ultrasound (IVUS) and
optical coherence tomography (OCT) were documented, any additional information was not obtained
except stent expansion. Routine 6-month follow-up angiography revealed no ﬁndings of restenosis.
Three representative imaging modalities, IVUS, OCT, and angioscopy were applied to visualize and
differentiate any structures within the PTFE-covered stent. Intravascular ﬁndings included, (1) vascular
structures outside the covered stent could be observed sufﬁciently by both IVUS and OCT at this time that
could not be seen at all just after implantation, (2) neointimal hyperplasia distributed dominantly at
both stent edges, and (3) in-stent micro thrombi still existed even 6 months after implantation.
Intravascular ﬁndings of PTFE-covered stent may vary between the observational periods. Furthermore,
vascular healing process of this special stent may be different from those of non-covered mesh stents.
<Learning objective: Even with the use of IVUS and OCT, it may be difﬁcult to evaluate apposition of
PTFE-covered stent just after implantation. However, it could be visualized as being sufﬁciently similar
to the other common stents at 6-month follow-up. Unique longitudinal NIH distribution (bilateral edge
dominant) was evaluated, and existence of micro thrombi within PTFE-covered stent even at 6 months.>
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Perforation of coronary arteries is a complication that is often
encountered during percutaneous coronary intervention. With the
advance of new devices and technologies, interventionalists
attempt to treat more complex lesions, including more calciﬁed
or tortuous arteries, which increases the complication of perfora-
tion. The use of a polytetraﬂuoroethylene (PTFE)-coated stent in
coronary perforation cases may stop the bleeding at perforation* Corresponding author at: 19-1, Uchimaru, Morioka-City, Iwate 020-8505, Japan.
Tel.: +81 19 651 5111; fax: +81 19 624 8371.
E-mail address: tomoitoh@iwate-med.ac.jp (T. Itoh).
http://dx.doi.org/10.1016/j.jccase.2014.11.004
1878-5409/ 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rightssites. This case report contains serial documentation using rare
multi-intravascular imaging devices for PTFE-coated stents.
Case report
This case report involves a 47-year-old Japanese male who had
previously undergone coronary bypass surgery. The patient did not
have hereditary factors, or the risk factors of hypertension,
dyslipidemia, and long-term smoking, causes of acute coronary
syndrome. In the year after coronary bypass surgery, a bare metal
stent (size unknown) was deployed from left main (LM) trunk to
left circumﬂex artery because of angina. The patient was
transferred to our hospital for treatment of left main in-stent
restenosis after bare metal stent implantation, because sufﬁcient reserved.
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calciﬁcation of his LM lesion. His bypass graft was previously
patent from left internal mammary artery to left anterior
descending artery.
A repeat coronary intervention was performed for this calciﬁed
LM lesion. Immediately after balloon (non-compliant 3.25/15 mm,
max 18 atm dilatation) dilatation following rotational atherectomy
(burr 1.25 and 1.5 mm, max 200,000 rotation), coronary perforation
occurred because of severe calciﬁcation and was treated with the
tortuous lesion from LM to circumﬂex branch. Finally, hemostasis
was achieved using a PTFE-covered stent (Jostent GraftMaster 3.0/
18 mm, Abbott, Abbott Park, IL, USA) after prolonged compression
by balloon (Fig. 1). Additional stent dilatation was performed using a
non-compliant balloon at a high pressure of 30 atm. Intravascular
ultrasound (IVUS) and optical coherence tomography (OCT) were
documented to evaluate apposition of the PTFE-covered stent
(Fig. 2). IVUS system was used, namely, Atlantis Pro-2 and Galaxy-2
system (Boston Scientiﬁc, Natick, MA, USA). Conventional IVUS
images were acquired using a 40-MHz mechanically rotating IVUS
catheter. OCT imaging was performed during occlusion of the
proximal coronary artery with a compliant balloon (4Fr occlusion
balloon catheter, Helios, Light Lab Imaging, Westford, MA, USA) and
continuous ﬂushing. The ﬂuid ﬂush comprised 1 part dextran 40 to
3 parts lactated Ringer’s solution. However, vascular structures
outside the stent were not adequately evaluated by either IVUS or
OCT because PTFE tube might interfere with ultrasound beam or
light penetration.
Follow-up coronary angiography, IVUS, OCT, and angioscopy
were obtained at 6 months. There was no ISR at the PTFE-covered
stent by coronary angiography (Fig. 1). Although vascular
structures outside of a PTFE-covered stent could not be observed
by IVUS or OCT just after implantation, they could be visualized
and differentiated at 6-month follow-up (Fig. 2). PTFE membrane
was clearly observed at baseline, however it became difﬁcult to
differentiate from surrounding tissue at 6-month follow-up.
Representative frames of bilateral stent edges and mid-portion
observed by OCT and angioscopy are shown in Fig. 3. Longitudinal
neointimal hyperplasia (NIH) distribution detected by OCTFig. 1.
A repeat coronary intervention was performed for left main lesion with seve
angioplasty, coronary perforation occurred. Red arrows show perforation site 
implanted from left main lesion to proximal of left circumﬂex artery. Yellow 
there was no in-stent restenosis in PTFE-covered stent. PCI, percutaneous codemonstrated a unique pattern. NIH was dominantly distributed
at both stent edges. In contrast, neointimal coverage around the
stent mid-portion was thin. According to angioscopy, the middle of
the PTFE-covered stent was almost NSC [1] (angioscopic images of
Neointimal Stent Coverage) Grade 0 (no neointima found on stent
struts) or partially Grade 1 (struts were visible under the thin
neointima). Furthermore, several subclinical micro thrombi were
observed in mid lesion of PTFE-covered stent by OCT (Fig. 4).
Proprietary ofﬂine software (Light Lab Imaging) was used to
delineate the lumen contours of each cross-sectional image.
Lumen, stent, and neointimal thickness mean areas and volumes
were calculated every 5 frames along the entire stented segment.
Standard deﬁnitions of cross-sectional area and volume measure-
ments were applied as previously reported [2–4].
We analyzed the OCT imaging inside a PTFE-covered stent using
proprietary ofﬂine software. We calculated every 5 frames (total of
720 Struts at 56 frames). The details about lumen proﬁle are shown
in Table 1. According to our data, there were 96% (688/720) well
apposed embedded covered struts. Although there was no
malapposed strut, 3% (24/720) of uncovered struts existed.
Fig. 5 shows the average NIH thickness at every frame from the
proximal lesion to distal lesion of the PTFE-covered stent. NIH
thickness of bilateral edges looked thick compared with that of
middle portion.
Discussion
This case report is unique because serial assessment by several
representative intravascular imaging modalities is available to
evaluate PTFE-covered stent. Interesting observations in this case
can be summarized as the following: (1) just after implantation of
PTFE-coated stent, PTFE was clearly visible as ‘‘light band’’ by IVUS
or OCT, and vascular structure beyond PTFE could not be evaluated
at all; (2) at 6-month follow-up, this ‘‘light band’’, suggesting PTFE,
could not be clearly differentiated anymore, and vascular
structures including intima and peri-stent tissue could be
evaluated sufﬁciently, similar to other common stents; (3) unique
longitudinal NIH distribution was evaluated (bilateral edgere calciﬁcation. After rotational atherectomy (burr 1.5 mm) and plain old balloon
of left main lesion. As a result, a polytetraﬂuoroethylene (PTFE)-covered stent was
arrows show range of PTFE-covered stent. After 6-month follow-up angiography,
ronary intervention.
Fig. 2.
Apposition of polytetraﬂuoroethylene (PTFE)-covered stent by optical coherence tomography (OCT) and intravascular ultrasound (IVUS) just after stent
implantation into perforated left main trunk and follow-up at 6 months after implantation of PTFE-covered stent. In the acute period, the outside of a stent cannot
be observed. However, it was possible to have observed with IVUS and OCT the outside of PTFE after 6 months without high-intensity image of PTFE.
Fig. 3.
Follow-up optical coherence tomography (OCT) and angioscopy of
polytetraﬂuoroethylene (PTFE)-covered stent after 6 months. Yellow
arrow shows range of PTFE-covered stent, yellow asterisk is angioscopy
wire. Neointimal hyperplasia (NIH) at stent proximal and distal edge
was observed in PTFE-covered stent by OCT from short-axis and
longitudinal images. NIH at stent mid lesion was not observed by OCT
and struts were visible by angioscopy (NSC grade 0 or 1).
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covered stent even at 6 months. General experiences of intravas-
cular imaging modalities for PTFE-covered stent are limited
[5–8]. To the best of our knowledge, this might be the ﬁrst report,
containing serial documentation using multi-intravascular imag-
ing devices for PTFE-coated stents.
The material of PTFE itself disturbs neither an ultrasound nor an
OCT signal. Just after deploying a stent, even if imaging modality is
used, there are small gaps between a PTFE-covered stent and the
surface of coronary arteries making it difﬁcult for observation, and
this may disturb ultrasound and OCT signals. Therefore, PTFE-
covered stent and vascular intima might integrate in the chronic
phase, small gaps might disappear, and it may become observable
by IVUS and OCT.
In terms of the variability of visibility of PTFE-covered stent,
vascular healing process for this material may play an important
role. The several microns small hole is innumerably open to PTFE-
covered stent, and is said that NIH stretches through the hole to it.
If vascularized tissue covers all the PTFE-covered stent, it would be
expected to become an organized lump containing PTFE and the
intensity of Echo backscatter and optical reﬂection become
comparatively uniform.
Unique NIH distribution may be the other issue to be discussed.
From our data, although it did not result in restenosis, it was clear
that NIH was distributed at proximal and distal edges (Fig. 5). Several
previous studies have indicated that neointimal hyperplasia
predominantly occurred at the most plaque accumulated sites.
Usually, (1) minimal lumen diameter site, which should be mostly
mid-portion of the stent, or (2) bilateral stent edges were
representative for bare metal stent restenosis. On the other hand,
NIH distribution patterns of drug-eluting stents (DES) were
somewhat different from bare metal stents (BMS) [9,10]. Statistically
Fig. 4.
Follow-up coronary optical coherence tomography (OCT) after 6 months. Micro thrombi (A to C) were observed in mid lesion of polytetraﬂuoroethylene-covered
stent by OCT. They were identiﬁed as low-backscattering projections in the lumen of the artery and without distal shadowing. Therefore these structures were
identiﬁed as white thrombus.
Table 1 Optical coherence tomography analysis data.
Mean lumen area (mm2) 3.09  0.67
Minimum lumen area (mm2) 1.95
Mean stent area (mm2) 4.48  0.79
Minimum stent area (mm2) 2.99
Mean neointimal area (mm2) 1.39  0.91
Lumen volume (mm3) 57.1
Stent volume (mm3) 82.8
Neointimal volume (mm3) 25.7
Total number of struts 720
1, Embedded covered struts 688
2, Protruding covered struts 8
3, Uncovered apposed struts 24
4, Uncovered and malapposed struts 0
T. Kimura et al. / Journal of Cardiology Cases 11 (2015) 91–9594signiﬁcant more neointimal hyperplasia can be observed at
bilateral stent edge portions. One report focusing on PTFE-covered
stent is available. Gercken et al. [7] reported that follow-up IVUS
interrogation demonstrated that neointimal proliferation occurred0
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Fig. 5.
Average neointimal hyperplasia (NIH) thickness at every frame from the proxim
was total of 720 struts at 56 frames (12.9  1.55 struts/frame). White thrombpredominantly at the stent edges. Furthermore, there is a report that
re-stenosis had occurred only at proximal and distal edges of PTFE-
covered stents at 6-month follow-up [8] and lumen late losses at
bilateral stent edges were larger than that of stent mid portion
[9]. Thus, longitudinal distribution pattern of NIH following PTFE-
covered stent implantation appeared to be similar to that of DESs.
Considering this nature, we speculate that NIH covering process
might be more predominant in bilateral stent edges than in stent
body, due to existence of PTFE material. One group reported that they
had used longer sirolimus-eluting stents beneath the PTFE-covered
stent for 9 consecutive coronary perforation cases in order to prevent
such edge restenosis, which appeared to be reasonable [11].
Although PTFE-coated stent was not equipped with antiproli-
ferative agent, this case suggested several ﬁndings of delayed
vascular responses, including existence of micro thrombi, and thin
NIH-covered portions. Thus, delayed vascular healing process may
be considered for this covered stent. In the RECOVERS trial [12],
PTFE-covered stents implanted in saphenous vein grafts showed a29 31 33 35 37 39 41 43 45 47 49 51 53 55
rame edgeDistal è
Hyperplasia thickness
al lesion to distal lesion of polytetraﬂuoroethylene-covered stent. Analysis object
i (Fig. 4) were observed for NIH around thin frame 35.
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conventional stents (10.3% vs 3.4%, respectively). Furthermore, a
previous study demonstrated a relatively high incidence of
subacute stent thrombosis (5.7%) [7]. Existence of PTFE material
on the surface of the relatively small caliber vessel may be more
thrombogenic until completely endothelialized. Also in our case,
the thrombus was observed for NIH around the thin frame (Frame
35, Fig. 5). Therefore, the possibility that platelet aggregation
happened in response to uncovered metal was suggested
[13]. Prolonged dual antiplatelet therapy compared with BMS
might be considered as suitable for this stent.
Finally, from our experience of simultaneous usage of
3 intravascular imaging modalities, we should remember that it
may be difﬁcult to judge strut apposition or vascular conditions
beyond PTFE membrane at the timing of the procedure no matter
how we select intravascular imaging modalities. However, it
should be meaningful because stent dimension can be sufﬁciently
measured using either IVUS or OCT. In contrast, OCT may be the
most advantageous for the observation of PTFE-coated stent at the
timing of follow-up, thanks to its higher resolution which enables
precise assessments of in-stent structures such as neointimal
coverage, neointimal thickness, endothelialization, and micro
thrombi, without substantial information losses. Further clinical
experiences may warrant our current experiences.
Conclusion
Intravascular ﬁndings including vascular structures outside the
covered stent could be observed sufﬁciently by both IVUS and OCT
at this time that could not be seen at all just after implantation,
neointimal hyperplasia distributed dominantly at both stent edges,
and in-stent micro thrombi still existed even 6 months after
implantation. Intravascular ﬁndings of PTFE-covered stent may
vary between the observational periods. Furthermore, vascular
healing process of this special stent may be different from those of
non-covered mesh stents.
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